<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2448-8909</journal-id>
<journal-title><![CDATA[Medicina crítica (Colegio Mexicano de Medicina Crítica)]]></journal-title>
<abbrev-journal-title><![CDATA[Med. crít. (Col. Mex. Med. Crít.)]]></abbrev-journal-title>
<issn>2448-8909</issn>
<publisher>
<publisher-name><![CDATA[Colegio Mexicano de Medicina Crítica A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2448-89092018000100027</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Índice leucoglucémico como predictor de complicaciones en el síndrome coronario agudo]]></article-title>
<article-title xml:lang="en"><![CDATA[Leuko-glycemic index and complications in patients with acute coronary syndrome]]></article-title>
<article-title xml:lang="pt"><![CDATA[Índice leuco-glicêmico como preditor de complicações na síndrome coronariana aguda]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martínez Saldaña]]></surname>
<given-names><![CDATA[Abad]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mendoza Rodríguez]]></surname>
<given-names><![CDATA[Martín]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[López González]]></surname>
<given-names><![CDATA[Alfonso]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital General La Villa  ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>02</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>02</month>
<year>2018</year>
</pub-date>
<volume>32</volume>
<numero>1</numero>
<fpage>27</fpage>
<lpage>33</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2448-89092018000100027&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2448-89092018000100027&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2448-89092018000100027&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Objetivo:  Evaluar la asociación del índice leucoglucémico y las complicaciones en pacientes con síndrome coronario agudo.  Material y métodos:  Se realizó un estudio descriptivo, transversal, retrospectivo en 34 pacientes con diagnóstico de síndrome coronario agudo, SCA: infarto agudo al miocardio con elevación del segmento ST, infarto agudo al miocardio sin elevación del segmento ST y angina inestable, que ingresaron del 01 de mayo de 2016 al 31 de mayo de 2017 a la Unidad de Cuidados Intensivos. Se registraron los datos clínicos durante las primeras 72 horas del evento, así como los resultados de laboratorio: glucemia y cuenta de leucocitos a su ingreso. A partir de estos datos, se calculó el índice leucoglucémico y se evaluó su valor pronóstico mediante el uso de la prueba de &#967;2.  Resultados:  A la población en estudio se le aplicó el índice leucoglucémico y se formaron cuatro grupos de acuerdo al puntaje que se obtuvo al realizar la clasificación: grado I, de 0-800 puntos; grado II, de 801-1,600 puntos; grado III, de 1,601-2,400 puntos; y grado IV, más de 2,400 puntos. El de mayor prevalencia fue el grupo 2 (801-1,600 puntos), con 38.24%, seguido del grupo 4 (&gt; 2,400 puntos), con 35.29%. La mortalidad a las 72 horas fue de 23.53%. Las arritmias se presentaron en 50% de los casos.  Conclusiones:  No se encontró correlación estadísticamente significativa (p &gt; 0.05) entre el índice leucoglucémico y las complicaciones.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Objective:  To evaluate the association of the leuko-glycemic index and complications in patients with acute coronary syndrome (ACS).  Material and methods:  A descriptive, cross-sectional, retrospective study was performed in 34 patients diagnosed with acute coronary syndrome, ACS: acute myocardial infarction with ST segment elevation, acute myocardial infarction without ST segment elevation and unstable angina, who entered the Intensive Care Unit from May 1, 2016 to May 31, 2017. Clinical data were recorded during the first 72 hours of the event, as well as the laboratory results, which included glycemia and leukocyte count at admission. From these data, the leukoglycemic index was calculated and its prognostic value was evaluated by the use of the &#967; 2 test.  Results:  The leuko-glycemic index was applied to the population under study and four groups were formed according to the classification obtained: grade I, 0-800 points; grade II, 801-1600 points; grade III, 1601-2400 points; and grade IV, more than 2400 points. The highest prevalence was found in group 2 (800-1601 points), with 38.24%, followed by group 4 (&gt; 2400 points), with 35.29%. The mortality at 72 hours was 23.53%. Arrhythmias occurred in 50% of the cases.  Conclusions:  There was no statistically significant correlation (p &gt; 0.05) between the leuko-glycemic index and complications.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo:  Objetivo:  Avaliar a associação do índice leuco-glicêmico e as complicações em pacientes com Síndrome Coronariana Agudo.  Material e métodos:  Foi realizado um estudo descritivo, transversal, retrospectivo em 34 pacientes diagnosticados com Síndrome Coronariana Aguda «SCA»: infarto agudo do miocárdio com supradesnivelamento do segmento ST, infarto agudo do miocárdio sem elevação do segmento ST e angina instável, que foram admitidos na UTI de 1 Maio 2016 a 31 de maio de 2017. Se registaram os dados clínicos durante as primeiras 72 horas do evento, bem como o laboratório, que incluía a glicemia e a contagem de leucócitos na admissão. A partir desses dados foi calculado o índice leuco-glicêmico e seu valor prognóstico foi avaliado pelo uso do teste &#967;2.  Resultados:  O índice leuco-glicêmico foi aplicado à população em estudo e foram formados 4 grupos de acordo com a classificação obtida: (grau I 0 - 800 pontos, grau II 801-1600 pontos, grau III 1601-2400 pontos e grau IV mais de 2401 pontos). A maior prevalência foi o grupo 2 (800-1601 pontos) com 38.24%, seguido pelo grupo 4 (&gt; 2401 pontos) com 35.29%. A mortalidade em 72 horas foi de 23.53%. As arritmias ocorreram em 50% dos casos.  Conclusões:  Não houve nenhuma correlação estatisticamente significativa (p &gt; 0.05) entre o índice leuco-glicêmico e as complicações.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[SCA]]></kwd>
<kwd lng="es"><![CDATA[índice leucoglucémico]]></kwd>
<kwd lng="en"><![CDATA[ACS]]></kwd>
<kwd lng="en"><![CDATA[leuko-glycemic index]]></kwd>
<kwd lng="pt"><![CDATA[SCA]]></kwd>
<kwd lng="pt"><![CDATA[índice leuco-glicêmico]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Quiroga]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Conci]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Zelaya]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Isa]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pacheco]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Sala]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estratificación del riesgo en el infarto agudo de miocardio según el índice leucoglucémico. ¿El &#8220;Killip-Kimball&#8221; de laboratorio?]]></article-title>
<source><![CDATA[Rev Fed Arg Cardiol]]></source>
<year>2010</year>
<volume>39</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>29-34</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[León]]></surname>
<given-names><![CDATA[AE]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[FG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Leucograma y glucemia en el pronóstico de pacientes con síndrome coronario agudo. Utilidad del índice leucoglucémico]]></article-title>
<source><![CDATA[Cor Salud]]></source>
<year>2011</year>
<volume>3</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>93-102</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thygesen]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Alpert]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Jaffe]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Maarten]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Documento de consenso de expertos. Tercera definición universal del infarto de miocardio]]></article-title>
<source><![CDATA[Rev Esp Cardiol]]></source>
<year>2013</year>
<volume>6</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>132.e1-e15</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Infarto agudo de miocardio. Documento de postura, Academia Nacional de Medicina]]></source>
<year>2014</year>
<page-range>1-33</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[León]]></surname>
<given-names><![CDATA[AE]]></given-names>
</name>
<name>
<surname><![CDATA[Moreno]]></surname>
<given-names><![CDATA[MF]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[FG]]></given-names>
</name>
<name>
<surname><![CDATA[Vega]]></surname>
<given-names><![CDATA[FL]]></given-names>
</name>
<name>
<surname><![CDATA[Rabassa]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Índice leucoglucémico como marcador pronóstico de la evolución intrahospitalaria en pacientes con infarto agudo de miocardio con elevación del ST]]></article-title>
<source><![CDATA[Clin Invest Arterioscl]]></source>
<year>2014</year>
<volume>26</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>168-75</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Valero]]></surname>
<given-names><![CDATA[HA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores relacionados con la evolución intrahospitalaria del síndrome coronario agudo]]></article-title>
<source><![CDATA[Revista Cubana de Cardiología. CorSalud]]></source>
<year>2015</year>
<volume>7</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>161-8</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[WC]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[HC]]></given-names>
</name>
<name>
<surname><![CDATA[Fang]]></surname>
<given-names><![CDATA[HY]]></given-names>
</name>
<name>
<surname><![CDATA[Hsueh]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[CH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comparison of different strategies for acute ST-segment elevation myocardial infarction with high thrombus burden in clinical practice: symptom-free outcome at one year]]></article-title>
<source><![CDATA[Heart Lung]]></source>
<year>2015</year>
<volume>44</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>487-93</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fernández]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Mortalidad de síndromes coronarios agudos en México]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pesaro]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Nicolau]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Serrano]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Vinicius]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Karbstein]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Giráldez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Influencia de leucocitos y glucemia en el pronóstico de pacientes con infarto agudo de miocardio]]></article-title>
<source><![CDATA[Arq Bras Cardiol]]></source>
<year>2009</year>
<volume>92</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>84-9</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Erkol]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Oduncu]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Turan]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Kiliçgedik]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Karabay]]></surname>
<given-names><![CDATA[CY]]></given-names>
</name>
<name>
<surname><![CDATA[Akgün]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Neutrophil to lymphocyte ratio in acute ST-segment elevation myocardial infarction]]></article-title>
<source><![CDATA[Am J Med Sci]]></source>
<year>2014</year>
<volume>348</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>37-42</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shah]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Berzingi]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Mumtaz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Jasper]]></surname>
<given-names><![CDATA[JB]]></given-names>
</name>
<name>
<surname><![CDATA[Goswami]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Morsy]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Meta-analysis comparing complete revascularization versus infarct-related only strategies for patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease]]></article-title>
<source><![CDATA[Am J Cardiol]]></source>
<year>2016</year>
<volume>118</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1466-72</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hirschson]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
<name>
<surname><![CDATA[Higa]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Merlo]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Domine]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Blanco]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Blanco]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prognostic value of the leuko-glycemic index in acute myocardial infarction. Results from the SCAR multicenter registry]]></article-title>
<source><![CDATA[Rev Argent Cardiol]]></source>
<year>2014</year>
<volume>82</volume>
<page-range>500-5</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Panorama del IAM con elevación del segmento ST en México]]></article-title>
<source><![CDATA[Rev Fed Arg Cardiol]]></source>
<year>2013</year>
<volume>42</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>168-9</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Iaconis]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Caldas]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Valor pronóstico del índice leuco-glucémico en el stroke isquémico agudo]]></article-title>
<source><![CDATA[Curso Internacional de Investigación]]></source>
<year>2012</year>
<publisher-loc><![CDATA[Buenos Aires, Argentina ]]></publisher-loc>
<publisher-name><![CDATA[Asociación Médica Argentina]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Iwakura]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Stress hyperglycemia and micro vascular obstruction after acute myocardial infarction]]></article-title>
<source><![CDATA[Journal of Cardiology]]></source>
<year>2015</year>
<volume>65</volume>
<page-range>270-1</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jiménez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Arguedas]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Romero]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[El síndrome coronario agudo y otros diagnósticos provocan subregistro del infarto agudo de miocardio en el Hospital México, Costa Rica]]></article-title>
<source><![CDATA[Acta Médica Costarricense]]></source>
<year>2013</year>
<volume>55</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>24-30</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Suleiman]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Hammerman]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Boulos]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Kapeliovich]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Suleiman]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Agmon]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2005</year>
<volume>111</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>754-60</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
